Literature DB >> 16040401

Peroxisome proliferator-activated receptors and their relevance to dermatology.

Peter S Friedmann1, Hywel L Cooper, Eugene Healy.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily and are expressed in a variety of tissues including skin and cells of the immune system. They act as ligand-dependent transcription factors which heterodimerize with retinoid X receptors to allow binding to and activation of PPAR responsive genes. Through this mechanism, PPAR ligands can control a wide range of physiological processes. Based on their effects in vitro and in vivo PPAR agonists and antagonists have the potential to become important therapeutic agents for the treatment of various skin diseases. PPARs can also be activated directly by phosphorylation to have ligand-independent effects. This review will discuss the physiology of PPARs relating this to skin pathology and their role as a target for novel therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040401     DOI: 10.1080/00015550510030104

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

Review 1.  Macrophage polarization: the link between inflammation and related diseases.

Authors:  Samina Bashir; Yadhu Sharma; Asif Elahi; Farah Khan
Journal:  Inflamm Res       Date:  2016-01       Impact factor: 4.575

2.  The peroxisome proliferator-activated receptor gamma system regulates ultraviolet B-induced prostaglandin e(2) production in human epidermal keratinocytes.

Authors:  Raymond L Konger; Kellie Clay Martel; Danielle Jernigan; Qiwei Zhang; Jeffrey B Travers
Journal:  PPAR Res       Date:  2010-05-19       Impact factor: 4.964

Review 3.  Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects.

Authors:  Raymond L Konger; Gopal K Marathe; Yongxue Yao; Qiwei Zhang; Jeffrey B Travers
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-05-02       Impact factor: 3.072

Review 4.  The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells.

Authors:  Vladimir V Sobolev; Ekaterina Tchepourina; Irina M Korsunskaya; Natalia A Geppe; Svetlana N Chebysheva; Anna G Soboleva; Alexandre Mezentsev
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

5.  The efficacy and safety of pioglitazone in psoriasis vulgaris: A meta-analysis of randomized controlled trials.

Authors:  Pengfei Chen; Xiubing Chen; Lei Lei; Yang Zhang; Jianjun Xiang; Jinxia Zhou; Jun Lv
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.